Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - RELMADA THERAPEUTICS, INC. | f10q0918ex32-1_relmadatherap.htm |
| EX-31.2 - CERTIFICATION - RELMADA THERAPEUTICS, INC. | f10q0918ex31-2_relmadatherap.htm |
| EX-31.1 - CERTIFICATION - RELMADA THERAPEUTICS, INC. | f10q0918ex31-1_relmadatherap.htm |
| EX-10.3 - REGISTRATION RIGHTS AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER - RELMADA THERAPEUTICS, INC. | f10q0918ex10-3_relmadatherap.htm |
| EX-10.2 - SUBSCRIPTION AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER 2, 201 - RELMADA THERAPEUTICS, INC. | f10q0918ex10-2_relmadatherap.htm |
| EX-10.1 - UNIT PURCHASE AGREEMENT, DATED AS OF OCTOBER 12 AND 18, 2018, AND NOVEMBER 2, 20 - RELMADA THERAPEUTICS, INC. | f10q0918ex10-1_relmadatherap.htm |
| EX-4.1 - FORM OF 2018 WARRANT - RELMADA THERAPEUTICS, INC. | f10q0918ex4-1_relmadatherap.htm |
| 10-Q - QUARTERLY REPORT - RELMADA THERAPEUTICS, INC. | f10q0918_relmadatherap.htm |
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Relmada Therapeutics, Inc. (the “Company”) on Form 10-Q for the three months ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sergio Traversa, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| 2. | The information contained in the Quarterly Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. |
| Relmada Therapeutics, Inc. | ||
| By: | /s/ Sergio Traversa | |
| Sergio Traversa | ||
Chief Executive Officer and Interim Chief Financial Officer |
||
November 13, 2018